Delving into the Latest Updates on Shanghai Xinyi Jinzhu Pharmaceutical Co. Ltd. with Synapse

Overview

Tags

Nervous System Diseases

Immune System Diseases

Neoplasms

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Immune System Diseases	1
Nervous System Diseases	1
Neoplasms	1

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

AChE(Acetylcholinesterase)	1

上海信谊金朱药业有限公司生产的柳氮磺吡啶口服混悬液与Rosemont Pharmaceuticals Ltd持证的柳氮磺吡啶口服混悬液在中国健康受试者中的单中心、随机、开放、单次给药、两制剂、两序列、重复交叉、空腹及餐后状态下的生物等效性研究

[Translation] A single-center, randomized, open-label, single-dose, two-formulation, two-sequence, repeated crossover, fasting and fed bioequivalence study of sulfasalazine oral suspension produced by Shanghai Xinyi Jinzhu Pharmaceutical Co., Ltd. and sulfasalazine oral suspension licensed by Rosemont Pharmaceuticals Ltd in healthy Chinese subjects

评价上海信谊金朱药业有限公司生产的柳氮磺吡啶口服混悬液与Rosemont Pharmaceuticals Ltd持证的柳氮磺吡啶口服混悬液空腹及餐后单次口服给药在健康人群中的生物等效性。同时观察受试制剂和参比制剂在中国健康受试者中的安全性。

[Translation]

To evaluate the bioequivalence of sulfasalazine oral suspension produced by Shanghai Xinyi Jinzhu Pharmaceutical Co., Ltd. and sulfasalazine oral suspension certified by Rosemont Pharmaceuticals Ltd. in healthy subjects after single oral administration on an empty stomach or after a meal. At the same time, the safety of the test and reference preparations in healthy Chinese subjects was observed.

Start Date22 Dec 2023

Sponsor / Collaborator

Shanghai Xinyi Jinzhu Pharmaceutical Co. Ltd.

100 Clinical Results associated with Shanghai Xinyi Jinzhu Pharmaceutical Co. Ltd.

Login to view more data

0 Patents (Medical) associated with Shanghai Xinyi Jinzhu Pharmaceutical Co. Ltd.

Login to view more data

1

Literatures (Medical) associated with Shanghai Xinyi Jinzhu Pharmaceutical Co. Ltd.

31 Aug 2020·Pharmaceutical Care and Research

Preparation of compound ketoacid pellets capsules and study on its stability influencing factors

Author: Xu, Xin ; Liu, Zhepeng

100 Deals associated with Shanghai Xinyi Jinzhu Pharmaceutical Co. Ltd.

Login to view more data

100 Translational Medicine associated with Shanghai Xinyi Jinzhu Pharmaceutical Co. Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 25 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Approved

1

Login to view more data